Submitted by amarin on Fri, 12/08/2017 - 04:49 Home ID Reference 9051 News title Amarin Announces FDA Acceptance of Supplemental New Drug Application (sNDA) for Vascepa(R) for the Treatment of Patients With High Triglycerides (>200 mg/dL and
